10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 107 filers reported holding 10X GENOMICS INC in Q1 2020. The put-call ratio across all filers is 0.47 and the average weighting 2.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $451,729 | +43.6% | 10,951 | +94.4% | 0.00% | – |
Q2 2023 | $314,602 | +11.0% | 5,634 | +10.9% | 0.00% | – |
Q1 2023 | $283,525 | -81.7% | 5,082 | -88.0% | 0.00% | -100.0% |
Q4 2022 | $1,545,748 | +104.7% | 42,419 | +59.9% | 0.00% | +100.0% |
Q3 2022 | $755,000 | -89.7% | 26,532 | -83.7% | 0.00% | -80.0% |
Q2 2022 | $7,359,000 | -25.1% | 162,652 | +26.0% | 0.01% | -16.7% |
Q1 2022 | $9,823,000 | -29.2% | 129,117 | +38.6% | 0.01% | -14.3% |
Q4 2021 | $13,873,000 | +33.1% | 93,129 | +30.1% | 0.01% | +16.7% |
Q3 2021 | $10,423,000 | -42.3% | 71,596 | -22.4% | 0.01% | -45.5% |
Q2 2021 | $18,067,000 | +35.1% | 92,261 | +24.9% | 0.01% | +22.2% |
Q1 2021 | $13,374,000 | +33.3% | 73,889 | +4.2% | 0.01% | +50.0% |
Q4 2020 | $10,036,000 | +63.8% | 70,878 | +44.2% | 0.01% | +50.0% |
Q3 2020 | $6,128,000 | +1762.6% | 49,153 | +1235.7% | 0.00% | – |
Q2 2020 | $329,000 | +585.4% | 3,680 | +379.2% | 0.00% | – |
Q1 2020 | $48,000 | +26.3% | 768 | +53.6% | 0.00% | – |
Q4 2019 | $38,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |